Analysts Say Tango (TNGX) is Worth $10.43—Here’s Why It Might Go Even Higher
Tango Therapeutics Inc. (NASDAQ:TNGX) is a clinical-stage biotechnology company at the forefront of developing targeted cancer therapies using…
Is Prelude (PRLD) the Next Biotech Titan? Investors Are Watching this Stock Closely
Prelude Therapeutics Incorporated (NASDAQ:PRLD) is a clinical-stage biopharmaceutical company committed to transforming the treatment of cancer through the…
This $1 Stock Has a $6 Price Target—Is Pyxis (PYXS) the Best Cheap Biotech Play Right Now?
Pyxis Oncology Inc. (NASDAQ:PYXS) is a clinical-stage biotechnology company committed to redefining the landscape of cancer therapy through…
Foghorn Therapeutics (FHTX) is Quietly Building a Biotech Empire—Here’s Why Investors Are Watching
Foghorn Therapeutics Inc. (NASDAQ:FHTX) is a pioneering clinical-stage biotechnology company that is revolutionizing the treatment of cancer and…
ADC Therapeutics (ADCT): The Cancer-Fighting Biotech With a 200%+ Upside Potential
ADC Therapeutics SA (NASDAQ:ADCT) is a commercial-stage biotechnology company pioneering the development of next-generation antibody-drug conjugates (ADCs) for…
Amylyx (AMLX) Could Be the Biotech Underdog Set to Dominate Neurology in 2025
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) is a pioneering biopharmaceutical company committed to developing novel and life-extending treatments for people…
Alkermes (ALKS) Could Be the Best Neuroscience Stock to Own This Decade
Alkermes plc (NASDAQ:ALKS) is a fully integrated global biopharmaceutical company focused on the development, manufacture, and commercialization of…
Corbus (CRBP) has $149M in Cash & a Cancer Drug That Could Shock Wall Street
Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) is a U.S.-based clinical-stage biopharmaceutical company focused on developing transformative therapies that address…
89bio (ETNB) is on Every Analyst’s Watchlist
89bio, Inc. (NASDAQ:ETNB) is a cutting-edge clinical-stage biopharmaceutical company pioneering the development of transformative therapies for serious liver…
60 Degrees Pharmaceuticals (XTP) Could Be the Next $10 Biotech
60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) is a clinical-stage specialty pharmaceutical company focused on developing and commercializing innovative medicines…
4D Molecular Therapeutics (FDMT) Could Be the Next $5 Billion Gene Therapy Titan
4D Molecular Therapeutics Inc. (NASDAQ:FDMT) is a clinical-stage biotechnology company revolutionizing the field of genetic medicine through its…
Firefly Neuroscience (AIFF) Skyrockets 483%
Firefly Neuroscience Inc. (NASDAQ:AIFF) is a cutting-edge biotechnology and medical technology company revolutionizing the way neurological conditions are…
Organogenesis (ORGO): The $3 Stock Disrupting Wound Healing & Regenerative Medicine
Organogenesis Holdings Inc. (NASDAQ:ORGO) is a leading regenerative medicine company headquartered in Canton, Massachusetts, dedicated to transforming the…
PepGen (PEPG) s Poised to Disrupt Rare Disease Therapy
PepGen Inc. (NASDAQ:PEPG) is a U.S.-based clinical-stage biotechnology company at the forefront of genetic medicine, focused on developing…
Enveric Biosciences (ENVB) Just Might Be the Most Undervalued Biotech in Mental Health
Enveric Biosciences Inc. (NASDAQ:ENVB) is a cutting-edge biotechnology company redefining the future of mental health treatment by developing…
Cumberland Pharma (CPIX) is Beating Big Pharma at Its Own Game
Founded in 1999 and headquartered in Nashville, Tennessee, Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) is a U.S.-based specialty pharmaceutical…
FDA-Approved Rosacea Drug Just Changed the Game for Journey Medical (DERM)
Journey Medical Corporation (NASDAQ:DERM) is a U.S.-based specialty pharmaceutical company focused on treating chronic dermatological conditions through FDA-approved…
Analysts Believe DBV Tech (DBVT) Could 10x After FDA Approval
DBV Technologies S.A. (NASDAQ:DBVT) is a late-stage clinical biopharmaceutical company based in France that is pioneering a groundbreaking…